Language During Inhalational Induction

Description

The aim of this study is to compare the impact of common (standard of care) language vs positive language used by clinicians during inhalational induction of anesthesia on anxiety and negative behaviors in children. This is a prospective randomized parallel group trial. Patients will be randomized 1:1 to the common/standard language group or the positive language group.

Conditions

Emergence Delirium, Anesthesia; Adverse Effect

Study Overview

Study Details

Study overview

The aim of this study is to compare the impact of common (standard of care) language vs positive language used by clinicians during inhalational induction of anesthesia on anxiety and negative behaviors in children. This is a prospective randomized parallel group trial. Patients will be randomized 1:1 to the common/standard language group or the positive language group.

A Prospective Randomized Study Comparing Positive Language vs Common Language During Inhalational Induction

Language During Inhalational Induction

Condition
Emergence Delirium
Intervention / Treatment

-

Contacts and Locations

Boston

Boston Children's Hospital, Boston, Massachusetts, United States, 02115

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * ASA 1 and 2 (Healthy Patients)
  • * Non-emergent cases
  • * 5-10 year olds
  • * Patients receiving inhalational induction
  • * Non-English speaking
  • * History of prior inhalational inductions
  • * Hearing difficulty
  • * Behavioral difficulty (Autism, Oppositional Defiant Disorder)
  • * Patients receiving premedication other than midazolam

Ages Eligible for Study

5 Years to 10 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Boston Children's Hospital,

John Fiadjoe, MD, PRINCIPAL_INVESTIGATOR, Boston Children's Hospital

Study Record Dates

2025-03-11